1-tert-Butylamino-3-(5,6,7,8,9,9a-hexahydro-4bH-benzo[3,4]cyclobuta[1,2]cyclohepten-2-yloxy)-propan-2-ol

ID: ALA353841

PubChem CID: 44378904

Max Phase: Preclinical

Molecular Formula: C20H31NO2

Molecular Weight: 317.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)NCC(O)COc1ccc2c(c1)[C@@H]1CCCCC[C@H]21

Standard InChI:  InChI=1S/C20H31NO2/c1-20(2,3)21-12-14(22)13-23-15-9-10-18-16-7-5-4-6-8-17(16)19(18)11-15/h9-11,14,16-17,21-22H,4-8,12-13H2,1-3H3/t14?,16-,17+/m0/s1

Standard InChI Key:  UZASONPNPYATSY-MWSTZMHHSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  1  0  0  0  0  0999 V2000
    1.8375   -0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8375   -0.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4417   -0.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4417   -0.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3167   -1.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3167    0.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7958    0.0208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3208    0.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -0.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2792    0.0083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7583    0.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -0.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2750    0.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2375    0.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9167    0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9167   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7625   -0.5875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3125    0.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8375    0.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8375    0.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5042   -0.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5042   -1.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7667   -0.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4375   -1.4917    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.4375    0.3208    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  2  2  0
  6  1  2  0
  7 13  1  0
  8  7  1  0
  9  6  1  0
 10  9  1  0
 11 14  1  0
 12  9  2  0
 13 11  1  0
 14 10  1  0
 15  3  1  0
 16  4  1  0
 17 11  1  0
 18  8  1  0
 19  8  1  0
 20  8  1  0
 21 15  1  0
 22 16  1  0
 23 21  1  0
  4 24  1  1
  3 25  1  1
  2  4  1  0
  5 12  1  0
 23 22  1  0
M  END

Associated Targets(Human)

ADRB1 Tclin Adrenergic receptor beta; ADRB1 & ADRB2 (240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 317.47Molecular Weight (Monoisotopic): 317.2355AlogP: 3.96#Rotatable Bonds: 5
Polar Surface Area: 41.49Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.76CX LogP: 3.88CX LogD: 1.57
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.86Np Likeness Score: -0.04

References

1. Carre MC, Youlassani A, Caubere P, Saint-Aubin-Floch A, Blanc M, Advenier C..  (1984)  Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.,  27  (6): [PMID:6145801] [10.1021/jm00372a016]

Source